炎症性腸疾患の持続可能性を達成する
Olga Maria Nardone1, Beatriz Gros2,3, Tommaso Lorenzo Parigi4,5
1Gastroenterology, Department of Public Health, University Federico II of Naples, Naples, Italy.
Journal of Crohn's & colitis
|February 19, 2026
まとめ
持続的な炎症性腸疾患 (IBD) の治療は,患者の治療結果を,実現可能性,手頃な価格,環境への影響とバランスをとります. このレビューでは,IBDを減らす方法を検討しています.
科学分野:
- 胃腸内科と環境衛生について
背景:
- 世界の炎症性腸疾患 (IBD) の負担は,特に低所得国において増加しています.
- IBDのケアにおける強化されたモニタリングと治療目標戦略は,持続可能性に関する懸念を提起しています.
- 現在のIBD管理は,コストの増加,治療負担,環境への影響につながる可能性があります.
研究 の 目的:
- 炎症性腸疾患 (IBD) の環境足跡を調査する.
- IBD管理における持続可能性の多面的な概念を探求し,臨床的,財務的,公平性,環境的要因を網羅する.
- 持続可能なヘルスケアモデルの中で,害を軽減し,患者のアウトカムを改善するための戦略を特定します.
主な方法:
- この研究は,ナラティブ・レビューである.
- IBDのケア,持続可能性,環境への影響に関する現在の文献をまとめています.
- 持続可能なIBD管理のための主要な戦略が議論されています.
主要な成果:
- IBDのケアにおける持続可能性を達成するには,患者中心のアプローチが必要です.
- 臨床効果と実現可能性,手頃な価格,そして環境への責任のバランスをとることは極めて重要です.
- 集中的なIBD管理戦略は,重大な環境的影響を及ぼす可能性があります.
結論:
- 持続的なIBDのケアは,世界的な負担と医療システムへの圧力の増大に対処するために不可欠です.
- 患者の健康と地球全体の福祉の両方をサポートするために,協調的で証拠に基づいたアプローチが必要です.
- 持続可能な実践を実装することで,環境被害を最小限に抑えながら,患者の治療結果を保ち,潜在的に改善することができます.
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
940
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
940
Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817
Inflammatory Bowel Disease V: Surgical Management
731
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
731
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
574
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
574


